Tuesday, 03 March, 2020
The current coronavirus (COVID-19) outbreak has been declared by the World Health Organisation (WHO) as a Public Health Emergency of International Concern according to the International Health Regulation. It is crucial to rapidly gain a better understanding of the newly identified virus, especially in relation to potential clinical and public health measures that can be put to immediate use to improve patients’ health and/or contain the spread of COVID-19.
Collaboration of private companies, academia, international organisations, public bodies etc. has the potential to accelerate the development of therapeutics and diagnostics to tackle this current and future outbreaks. The actions resulting from this fast-track IMI2 call will contribute to the pan-European efforts responding to this Public Health Emergency.
Proposals are expected to advance the knowledge specifically on COVID-19 and more widely on the coronavirus family with the aim of contributing to an efficient patient management and/or public health preparedness and response to current and future outbreaks of coronavirus infection.
Considering that this is a newly identified virus, the scope of this topic remains broad and must address at least one of the following objectives:
Preventive vaccines are specifically excluded from the scope of the call.
The total budget for this Call is €45 million.
Proposals must be made by a consortium of at least three independent legal entities, each established in a different EU Member State or associated country.
The deadline for submissions is 31 March 2020.